Jie Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jie Song has a total of 331 co-authors. Here are the top co-authors by number of shared publications:
Yan Liu
Institute for Health Innovation & Technology, National University of Singapore, Singapore, 117599, Singapore
23 shared publicationsJin Cheng
Institute of Nano Biomedicine and Engineering, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, China
19 shared publicationsSisi Fan
2nd Physics Institute, University of Stuttgart , Stuttgart 70569
16 shared publicationsBin Ji
Department of Disease Control, The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi, 214023, China
12 shared publicationsLinlin Tang
Hangzhou Institute of Medicine Chinese Academy of Sciences, Hangzhou, China
12 shared publications- Daxiang Cui
Medical and Engineering Cross Research Institute, The First Affiliated Hospital of Henan University, Kaifeng, China
11 shared publications
Latest Publications
- 30 July 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (8) , 826-841
Structure-alignment-driven cross-graph modeling for functional RNA design
- 30 July 2026
- Published by Springer Nature in Nature Computational Science
- Vol. 6 (8) , 826-841
Structure-alignment-driven cross-graph modeling for functional RNA design
- Open Access
- 26 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (26) , eaed2917
Long-stranded XNA-cssDNA hybrids for robust data storage
DNA is a promising medium for data storage due to its high density and low energy cost. Long-stranded DNA with minimal indexing improves storage density but suffers from poor stability. To address this, we introduce a long-stranded xeno nucleic acid–circular single-stranded DNA (XNA-cssDNA) hybrid strategy to enhance storage robustness. We evaluated multiple XNAs under extreme conditions and identified 2′-fluoro-arabinonucleic acid (FANA) as the optimal storage material. To overcome XNA synthesis length and speed limitations, we used a temperature-guided language model to evolve a FANA polymerase Tgo mut , which is ~4.4-fold faster than Tgo D4K and enables synthesis of strands exceeding 7500 nucleotides. Data-encoded cssDNA were produced using M13 bacteriophage. The resulting FANA-cssDNA hybrids show strong resistance to chemical and enzymatic degradation. Using a dual-strategy framework, we achieved reliable data writing and reading with 100% data recovery, even after DNA degradation, and successfully visualized encoded digital data and an enhanced green fluorescent protein gene in mammalian cells.
- 26 June 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (26) , eaed2917
Open AccessLong-stranded XNA-cssDNA hybrids for robust data storage
DNA is a promising medium for data storage due to its high density and low energy cost. Long-stranded DNA with minimal indexing improves storage density but suffers from poor stability. To address this, we introduce a long-stranded xeno nucleic acid–circular single-stranded DNA (XNA-cssDNA) hybrid strategy to enhance storage robustness. We evaluated multiple XNAs under extreme conditions and identified 2′-fluoro-arabinonucleic acid (FANA) as the optimal storage material. To overcome XNA synthesis length and speed limitations, we used a temperature-guided language model to evolve a FANA polymerase Tgo mut , which is ~4.4-fold faster than Tgo D4K and enables synthesis of strands exceeding 7500 nucleotides. Data-encoded cssDNA were produced using M13 bacteriophage. The resulting FANA-cssDNA hybrids show strong resistance to chemical and enzymatic degradation. Using a dual-strategy framework, we achieved reliable data writing and reading with 100% data recovery, even after DNA degradation, and successfully visualized encoded digital data and an enhanced green fluorescent protein gene in mammalian cells.
- 4 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (27) , 28157-28168
Dual-Spatially Confined Assembly of DNA Nanowall Stiffens Tumor Cells to Enhance Adoptive T-Cell Immunotherapy
Cellular softness acts as a mechanical immune checkpoint, suppressing T-cell mechanosensing and cytotoxicity to drive tumor immune evasion. However, existing approaches to modulate membrane stiffness lack specificity, limiting targeted therapeutic potential. Here, we report a dual-spatially confined DNA nanowall assembly strategy to enhance tumor cell stiffness, thereby augmenting the efficacy of adoptive T-cell immunotherapy. In acidic tumor microenvironments, low-pH-triggered membrane-anchored probes (tissue-level confinement) selectively guide the construction of a DNA nanowall on the inner leaflet of the tumor cell membrane (cellular-level confinement). This biomechanical reprogramming markedly increases tumor rigidity. When combined with adoptive T-cell transfer (ACT) immunotherapy, this strategy restores T-cell mechanical force generation capacity, significantly improving tumor killing outcomes in vitro and in murine solid tumor models. Our findings underscore the critical role of biophysical signals in cancer–immune interactions, demonstrating that targeting mechanical immune checkpoints can potentiate antitumor immunity. Furthermore, these discoveries bridge biophysics and oncology, offering a paradigm for precision cancer therapy through the spatiotemporal control of cellular mechanics.
- 4 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (27) , 28157-28168
Dual-Spatially Confined Assembly of DNA Nanowall Stiffens Tumor Cells to Enhance Adoptive T-Cell Immunotherapy
Cellular softness acts as a mechanical immune checkpoint, suppressing T-cell mechanosensing and cytotoxicity to drive tumor immune evasion. However, existing approaches to modulate membrane stiffness lack specificity, limiting targeted therapeutic potential. Here, we report a dual-spatially confined DNA nanowall assembly strategy to enhance tumor cell stiffness, thereby augmenting the efficacy of adoptive T-cell immunotherapy. In acidic tumor microenvironments, low-pH-triggered membrane-anchored probes (tissue-level confinement) selectively guide the construction of a DNA nanowall on the inner leaflet of the tumor cell membrane (cellular-level confinement). This biomechanical reprogramming markedly increases tumor rigidity. When combined with adoptive T-cell transfer (ACT) immunotherapy, this strategy restores T-cell mechanical force generation capacity, significantly improving tumor killing outcomes in vitro and in murine solid tumor models. Our findings underscore the critical role of biophysical signals in cancer–immune interactions, demonstrating that targeting mechanical immune checkpoints can potentiate antitumor immunity. Furthermore, these discoveries bridge biophysics and oncology, offering a paradigm for precision cancer therapy through the spatiotemporal control of cellular mechanics.
- 13 May 2026
- Published by Wiley in Small Methods
- Vol. 10 (11) , e70720
Programmable Circular Single‐Stranded DNA Acts as Recyclable Anti‐miRNA Nucleotides to Inhibit Colorectal Cancer
MicroRNA (miRNA) therapy represents an attractive approach for the treatment of colorectal cancer (CRC). However, the efficacy of therapy targeting a single oncomiRNA (oncomiR) is limited, as multiple oncomiRs often act simultaneously in promoting CRC development. In addition, current anti‐miRNA nucleotide (AMiN) design faces challenges, including high synthetic error rate and difficulty in synthesizing long oligonucleotides. Circular single‐stranded DNA (CssDNA), an ancient form of DNA that has gained increasing attention recently, is known for its easy synthesis, high stability, low error rate, and long size potential. Here, we develop a multi‐oncomiR targeting platform with low immunogenicity, high stability and long‐size potential using in vivo M13 phage‐generated CssDNA. This CssDNA acts as a sponge, which attracts and degrades multiple abnormally overexpressed oncomiRs in CRC. The degradation of oncomiRs promotes the expression of tumor suppressor genes (TSGs), inhibiting CRC development. Further, the degradation of oncomiRs from the sponge releases the free CssDNA for second round of action, which results in the efficacy and recyclability of CssDNA. It's visible to spread this novel, sequence customizable, multi‐oncomiR targeting platform using CssDNA as a stable, low‐immunogenic and recyclable AMiN in antagonizing miRNA‐mediated repression of TSG expression for other tumor suppression.
- 13 May 2026
- Published by Wiley in Small Methods
- Vol. 10 (11) , e70720
Programmable Circular Single‐Stranded DNA Acts as Recyclable Anti‐miRNA Nucleotides to Inhibit Colorectal Cancer
MicroRNA (miRNA) therapy represents an attractive approach for the treatment of colorectal cancer (CRC). However, the efficacy of therapy targeting a single oncomiRNA (oncomiR) is limited, as multiple oncomiRs often act simultaneously in promoting CRC development. In addition, current anti‐miRNA nucleotide (AMiN) design faces challenges, including high synthetic error rate and difficulty in synthesizing long oligonucleotides. Circular single‐stranded DNA (CssDNA), an ancient form of DNA that has gained increasing attention recently, is known for its easy synthesis, high stability, low error rate, and long size potential. Here, we develop a multi‐oncomiR targeting platform with low immunogenicity, high stability and long‐size potential using in vivo M13 phage‐generated CssDNA. This CssDNA acts as a sponge, which attracts and degrades multiple abnormally overexpressed oncomiRs in CRC. The degradation of oncomiRs promotes the expression of tumor suppressor genes (TSGs), inhibiting CRC development. Further, the degradation of oncomiRs from the sponge releases the free CssDNA for second round of action, which results in the efficacy and recyclability of CssDNA. It's visible to spread this novel, sequence customizable, multi‐oncomiR targeting platform using CssDNA as a stable, low‐immunogenic and recyclable AMiN in antagonizing miRNA‐mediated repression of TSG expression for other tumor suppression.
- 5 May 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
Coordination-driven liquid-to-solid phase transition and self-assembly of DNA–metal condensates
This study reveals a new mechanism of DNA–ferrous ion assembly: by coupling phase separation with self-assembly processes and precisely controlling the reaction conditions, we achieved the formation of nanospheres, nanofibers, and nanoribbons.
- 5 May 2026
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
Coordination-driven liquid-to-solid phase transition and self-assembly of DNA–metal condensates
This study reveals a new mechanism of DNA–ferrous ion assembly: by coupling phase separation with self-assembly processes and precisely controlling the reaction conditions, we achieved the formation of nanospheres, nanofibers, and nanoribbons.
- 30 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Switchable DNA-Scaffolded Multivalent Aptamer through Stimuli-Responsive Plug-and-Play Modules for Protein Regulation
Multivalent molecular interactions enhance binding affinity and enable functional regulation in biological systems, inspiring the development of multivalent materials for biosensing and biomedical applications. The capacity to reversibly switch between low-valency and multivalency as needed is key to regulating their function. However, current design strategies face challenges in enabling such switching within the same system through a response to multiple stimuli. Here, as a proof of concept, we demonstrate a switchable multivalent system for regulating thrombin activity. This system is based on thrombin aptamer-decorated DNA tile assembly and introduces stimuli-responsive plug-and-play modules that serve as dynamic, reversible, and orthogonal switches responding to the corresponding stimuli, including UV light, APE1, and RNase H. We construct three-layer switching cascades activated by one-, two-, or three stimuli to regulate thrombin activity. Building upon this programmable multivalent aptamer system, we further translate switchable modules into spatiotemporal control logic to construct a tristate circuit. We hope that the switchable DNA scaffold-based multivalent regulatory approach can provide a versatile modular platform with potential applications in precision medicine, biosensing, and biomaterials.
- 30 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
Switchable DNA-Scaffolded Multivalent Aptamer through Stimuli-Responsive Plug-and-Play Modules for Protein Regulation
Multivalent molecular interactions enhance binding affinity and enable functional regulation in biological systems, inspiring the development of multivalent materials for biosensing and biomedical applications. The capacity to reversibly switch between low-valency and multivalency as needed is key to regulating their function. However, current design strategies face challenges in enabling such switching within the same system through a response to multiple stimuli. Here, as a proof of concept, we demonstrate a switchable multivalent system for regulating thrombin activity. This system is based on thrombin aptamer-decorated DNA tile assembly and introduces stimuli-responsive plug-and-play modules that serve as dynamic, reversible, and orthogonal switches responding to the corresponding stimuli, including UV light, APE1, and RNase H. We construct three-layer switching cascades activated by one-, two-, or three stimuli to regulate thrombin activity. Building upon this programmable multivalent aptamer system, we further translate switchable modules into spatiotemporal control logic to construct a tristate circuit. We hope that the switchable DNA scaffold-based multivalent regulatory approach can provide a versatile modular platform with potential applications in precision medicine, biosensing, and biomaterials.
- Open Access
- 27 March 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
A low-toxicity circular single-stranded DNA platform for safe and potent IL-12 immunotherapy against hepatocellular carcinoma
Hepatocellular carcinoma (HCC) remains a major global health challenge, largely because of its immunosuppressive “cold” tumor microenvironment
- 27 March 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessA low-toxicity circular single-stranded DNA platform for safe and potent IL-12 immunotherapy against hepatocellular carcinoma
Hepatocellular carcinoma (HCC) remains a major global health challenge, largely because of its immunosuppressive “cold” tumor microenvironment
- 18 February 2026
- Published by Elsevier in Molecular Therapy
- Vol. 34 (6) , 3503-3517
Antigen-encoding circular single-stranded DNA for cancer vaccine
- 18 February 2026
- Published by Elsevier in Molecular Therapy
- Vol. 34 (6) , 3503-3517
Antigen-encoding circular single-stranded DNA for cancer vaccine
- Open Access
- 4 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Advances and challenges in non-canonical nucleic acids data storage
Canonical nucleic acids (DNA and RNA) naturally store genetic information with high density and programmability, making them promising candidates for molecular data storage. However, their susceptibility to degradation under harsh conditions, such as extreme pH, nuclease activity, and chemical attack, limits practical applications. In contrast, non-canonical nucleic acids (ncNAs) with natural or synthetic structural modifications exhibit enhanced stability and unique functional potential. This review systematically summarizes the fundamental properties of ncNAs, evaluates their suitability for molecular data storage, and discusses how their distinctive advantages may overcome the intrinsic limitations of canonical nucleic acids while addressing challenges in next-generation storage systems.
- 4 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessAdvances and challenges in non-canonical nucleic acids data storage
Canonical nucleic acids (DNA and RNA) naturally store genetic information with high density and programmability, making them promising candidates for molecular data storage. However, their susceptibility to degradation under harsh conditions, such as extreme pH, nuclease activity, and chemical attack, limits practical applications. In contrast, non-canonical nucleic acids (ncNAs) with natural or synthetic structural modifications exhibit enhanced stability and unique functional potential. This review systematically summarizes the fundamental properties of ncNAs, evaluates their suitability for molecular data storage, and discusses how their distinctive advantages may overcome the intrinsic limitations of canonical nucleic acids while addressing challenges in next-generation storage systems.
- Open Access
- 5 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-16
The tumor microenvironment enhances the expression of cssDNA by modulating cell cycle signaling pathways via SKP2
Circular single-stranded DNA (cssDNA), an emerging nucleic acid vector, exhibits significant clinical potential for treating genetic disorders, enabling gene editing, and advancing oncotherapy. Its unique attributes, including high stability, structural simplicity, conformational flexibility, and low molecular mass, establish it as a promising gene therapy tool. Our study reveals that cssDNA demonstrates superior expression efficiency over conventional plasmids across diverse tumor cell lines. Notably, cssDNA expression is enhanced under certain tumor microenvironment (TME) conditions (glucose deficiency, glutamine deficiency and hypoxia) compared to normal condition. Mechanistically, these TME conditions induce significant cell cycle perturbations, particularly pronounced G1 arrest. Intriguingly, transfected cssDNA expression peaks during the late G2/M phase, immediately preceding entry into the G1 phase. We further identify S-phase kinase-associated protein 2 (SKP2) as a critical regulator of cssDNA expression under TME conditions. SKP2 inhibition directly or indirectly notably enhances the expression levels of cssDNA. These findings confirm cssDNA’s advantages as a gene expression vector and how specific TME conditions modulate its expression via cell cycle and SKP2-dependent mechanisms in vitro. This work provides a scientific foundation for cssDNA-based cancer therapy and opens new avenues for future clinical translation.
- 5 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-16
Open AccessThe tumor microenvironment enhances the expression of cssDNA by modulating cell cycle signaling pathways via SKP2
Circular single-stranded DNA (cssDNA), an emerging nucleic acid vector, exhibits significant clinical potential for treating genetic disorders, enabling gene editing, and advancing oncotherapy. Its unique attributes, including high stability, structural simplicity, conformational flexibility, and low molecular mass, establish it as a promising gene therapy tool. Our study reveals that cssDNA demonstrates superior expression efficiency over conventional plasmids across diverse tumor cell lines. Notably, cssDNA expression is enhanced under certain tumor microenvironment (TME) conditions (glucose deficiency, glutamine deficiency and hypoxia) compared to normal condition. Mechanistically, these TME conditions induce significant cell cycle perturbations, particularly pronounced G1 arrest. Intriguingly, transfected cssDNA expression peaks during the late G2/M phase, immediately preceding entry into the G1 phase. We further identify S-phase kinase-associated protein 2 (SKP2) as a critical regulator of cssDNA expression under TME conditions. SKP2 inhibition directly or indirectly notably enhances the expression levels of cssDNA. These findings confirm cssDNA’s advantages as a gene expression vector and how specific TME conditions modulate its expression via cell cycle and SKP2-dependent mechanisms in vitro. This work provides a scientific foundation for cssDNA-based cancer therapy and opens new avenues for future clinical translation.